Skip to main content

Table 1 Clinical and demographic data of the studied patients

From: Can positron emission tomography–computed tomography-based three target lesions' total lesion glycolysis predict therapeutic response in Hodgkin Lymphoma?

n = 40
 Age, median (range) 30.5 years (19–85 years)
Gender
 Male 21
 Female 19
B symptoms
 Positive 24
 Negative 16
LDH
 Normal 4
 Elevated 36
ESR
 Normal 0
 Elevated 40
Ann Arbor stage
 I 8
 II 18
 III 6
 IV 8
Histology
 Nodular sclerosis 24
 Mixed cellularity 16
Target lesions
 LNs 75
 Other lesions 17
 Splenic lesions 10
 Bone lesions 8
RECIL response to CTH
 Complete response 26
 Partial response* 8
 Minor response** 4
 Stable disease 0
 Progressive disease 2
  1. *Partial Response means 30% or more reduction of the summation of longest dimensions of the target lesions but not a complete response with Positive FDG-PET findings
  2. **Minor Response means between 10 and 30% reduction of the summation of longest dimensions of the target lesions with FDG-PET findings